Articles6 March 2007
    Author, Article and Disclosure Information
    Background:

    Until recently, the tuberculin skin test was the only test for detecting latent tuberculosis (TB) infection, but 2 ex vivo interferon-γ release assays (IGRAs) are now commercially licensed.

    Purpose:

    To estimate sensitivity, specificity, and reproducibility of IGRAs (commercial or research versions of QuantiFERON [QFT] and Elispot) for diagnosing latent TB infection in healthy and immune-suppressed persons.

    Data Sources:

    The authors searched MEDLINE and reviewed citations of all original articles and reviews for studies published in English.

    Study Selection:

    Studies had evaluated IGRAs using Mycobacterium tuberculosis–specific antigens (RD1 antigens) and overnight (16- to 24-h) incubation times. Reference standards had to be clearly defined without knowledge of test results.

    Data Extraction and Quality Assessment:

    Specific criteria for quality assessment were developed for sensitivity, specificity, and reproducibility.

    Data Synthesis:

    When newly diagnosed active TB was used as a surrogate for latent TB infection, sensitivity of all tests was suboptimal, although it was higher with Elispot. No test distinguishes active TB from latent TB. Sensitivity of the tuberculin skin test and IGRAs was similar in persons who were categorized into clinical gradients of exposure. Pooled specificity was 97.7% (95% CI, 96% to 99%) and 92.5% (CI, 86% to 99%) for QFT and for Elispot, respectively. Both assays were more specific than the tuberculin skin test in samples vaccinated with bacille Calmette–Guérin. Elispot was more sensitive than the tuberculin skin test in 3 studies of immune-compromised samples. Discordant tuberculin skin test and IGRA reactions were frequent and largely unexplained, although some may be related to varied definitions of positive test results. Reversion of IGRA results from positive to negative was common in 2 studies in which it was assessed.

    Limitations:

    Most studies used cross-sectional designs with the inherent limitation of no gold standard for latent TB infection, and most involved small samples with a widely varying likelihood of true-positive and false-positive test results. There is insufficient evidence on IGRA performance in children, immune-compromised persons, and the elderly.

    Conclusions:

    New IGRAs show considerable promise and have excellent specificity. Additional studies are needed to better define their performance in high-risk populations and in serial testing. Longitudinal studies are needed to define the predictive value of IGRAs.

    References

    • 1. Mantoux MC La voie intradermique en tuberculinothérapie. Presse Med1912;20:146-48. Google Scholar
    • 2. World Health OrganizationThe WHO standard tuberculin test. Geneva: World Health Organization; 1963. Google Scholar
    • 3. Bearman JE Kleinman H Glyer VV Lacroix OM A study of variablilty in tuberculin test reading. Am Rev Respir Dis1964;90:913-9. [PMID: 14233795] MedlineGoogle Scholar
    • 4. Perez-Stable EJ Slutkin G A demonstration of lack of variability among six tuberculin skin test readers. Am J Public Health1985;75:1341-3. [PMID: 4051078] CrossrefMedlineGoogle Scholar
    • 5. Erdtmann FJ Dixon KE Llewellyn CH Skin testing for tuberculosis. Antigen and observer variability. JAMA1974;228:479-81. [PMID: 4594690] CrossrefMedlineGoogle Scholar
    • 6. Pouchot J Grasland A Collet C Coste J Esdaile JM Vinceneux P Reliability of tuberculin skin test measurement. Ann Intern Med1997;126:210-4. [PMID: 9027271] LinkGoogle Scholar
    • 7. Furcolow ML Watson KA Charron T Lowe J A comparison of the tine and Mono-Vacc tests with the intradermal tuberculin test. Am Rev Respir Dis1967;96:1009-27. [PMID: 6059186] MedlineGoogle Scholar
    • 8. Chaparas SD Vandiviere HM Melvin I Koch G Becker C Tuberculin test. Variability with the Mantoux procedure. Am Rev Respir Dis1985;132:175-7. [PMID: 4014862] MedlineGoogle Scholar
    • 9. Mazurek GH Jereb J Lobue P Iademarco MF Metchock B Vernon A Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep2005;54:49-55. [PMID: 16357824] MedlineGoogle Scholar
    • 10. Royal College of Physicians. Tuberculosis: national clinical guidelines for diagnosis, management, prevention, and control. London: Royal College of Physicians; 2006. Accessed at www.nice.org.uk. Google Scholar
    • 11. Comstock GW Edwards LB Livesay VT Tuberculosis morbidity in the U.S. Navy: its distribution and decline. Am Rev Respir Dis1974;110:572-80. [PMID: 4429253] MedlineGoogle Scholar
    • 12. Comstock GW Livesay VT Woolpert SF The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol1974;99:131-8. [PMID: 4810628] CrossrefMedlineGoogle Scholar
    • 13. Ferebee SH Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc1970;26:28-106. [PMID: 4903501] MedlineGoogle Scholar
    • 14. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. International Union Against Tuberculosis Committee on Prophylaxis. Bull World Health Organ1982;60:555-64. [PMID: 6754120] MedlineGoogle Scholar
    • 15. Nolan CM Elarth AM Tuberculosis in a cohort of Southeast Asian Refugees. A five-year surveillance study. Am Rev Respir Dis1988;137:805-9. [PMID: 3354985] CrossrefMedlineGoogle Scholar
    • 16. Wood R Maartens G Lombard CJ Risk factors for developing tuberculosis in HIV-1-infected adults from communities with a low or very high incidence of tuberculosis. J Acquir Immune Defic Syndr2000;23:75-80. [PMID: 10708059] CrossrefMedlineGoogle Scholar
    • 17. Selwyn PA Hartel D Lewis VA Schoenbaum EE Vermund SH Klein RS et alA prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med1989;320:545-50. [PMID: 2915665] CrossrefMedlineGoogle Scholar
    • 18. Grzybowski S Ontario studies on tuberculin sensitivity. Can J Public Health1965;56:181-92. [PMID: 14285275] MedlineGoogle Scholar
    • 19. Falk A Fuchs GF Prophylaxis with isoniazid in inactive tuberculosis. A Veterans Administration Cooperative Study XII. Chest1978;73:44-8. [PMID: 340155] CrossrefMedlineGoogle Scholar
    • 20. Hawken MP Meme HK Elliott LC Chakaya JM Morris JS Githui WA et alIsoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized, controlled trial. AIDS1997;11:875-82. [PMID: 9189212] CrossrefMedlineGoogle Scholar
    • 21. Zamora J Abraira V Muriel A Khan K Coomarasamy A Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol2006;6:31. [PMID: 16836745] CrossrefMedlineGoogle Scholar
    • 22. Lee JY Choi HJ Park IN Hong SB Oh YM Lim CM et alComparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J2006;28:24-30. [PMID: 16611658] CrossrefMedlineGoogle Scholar
    • 23. Ferrara G Losi M D’Amico R Roversi P Piro R Meacci M et alUse in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet2006;367:1328-34. [PMID: 16631911] CrossrefMedlineGoogle Scholar
    • 24. Goletti D Carrara S Vincenti D Saltini C Rizzi EB Schininà V et alAccuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect2006;12:544-50. [PMID: 16700703] CrossrefMedlineGoogle Scholar
    • 25. An Q Buxton D Hendricks A Robinson L Shah J Lu L et alComparison of amplified Q beta replicase and PCR assays for detection of Mycobacterium tuberculosis. J Clin Microbiol1995;33:860-7. [PMID: 7540627] CrossrefMedlineGoogle Scholar
    • 26. Dogra S, Narang P, Mendiratta DK, Chaturvedi P, Reingold AL, Colford JM Jr, et al. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect. 2006. DOI: 10.1016/J.Jinf.2006.04.007 (electronic access). [PMID: 16733068] Google Scholar
    • 27. Lalvani A Pathan AA McShane H Wilkinson RJ Latif M Conlon CP et alRapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med2001;163:824-8. [PMID: 11282752] CrossrefMedlineGoogle Scholar
    • 28. Lalvani A Nagvenkar P Udwadia Z Pathan AA Wilkinson KA Shastri JS et alEnumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis2001;183:469-77. [PMID: 11133379] CrossrefMedlineGoogle Scholar
    • 29. World Health OrganizationTuberculosis Research CentreFurther studies of geographic variation in naturally acquired tuberculin sensitivity. Bull World Health1955;22:63-83. Google Scholar
    • 30. Kang YA Lee HW Yoon HI Cho B Han SK Shim YS et alDiscrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA2005;293:2756-61. [PMID: 15941805] CrossrefMedlineGoogle Scholar
    • 31. Lalvani A Pathan AA Durkan H Wilkinson KA Whelan A Deeks JJ et alEnhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet2001;357:2017-21. [PMID: 11438135] CrossrefMedlineGoogle Scholar
    • 32. Harada N Nakajima Y Higuchi K Sekiya Y Rothel J Mori T Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol2006;27:442-8. [PMID: 16671023] CrossrefMedlineGoogle Scholar
    • 33. Diel R Nienhaus A Lange C Meywald-Walter K Forssbohm M Schaberg T Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res2006;7:77. [PMID: 16707012] CrossrefMedlineGoogle Scholar
    • 34. Brock I Weldingh K Lillebaek T Follmann F Andersen P Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med2004;170:65-9. [PMID: 15087297] CrossrefMedlineGoogle Scholar
    • 35. Porsa E Cheng L Seale MM Delclos GL Ma X Reich R et alComparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol2006;13:53-8. [PMID: 16426000] CrossrefMedlineGoogle Scholar
    • 36. Hill PC Brookes RH Adetifa IM Fox A Jackson-Sillah D Lugos MD et alComparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics2006;117:1542-8. [PMID: 16651307] CrossrefMedlineGoogle Scholar
    • 37. Cellestis. QuantiFERON Precision and reproducibility report. Accessed at www.cellestis.com/IRM/content/gold/Precisionproductivity.pdf on 27 February 27 2006. Google Scholar
    • 38. Aiken AM Hill PC Fox A McAdam KP Jackson-Sillah D Lugos MD et alReversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis2006;6:66. [PMID: 16573826] CrossrefMedlineGoogle Scholar
    • 39. Pai M Joshi R Dogra S Mendiratta DK Narang P Kalantri S et alSerial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med2006;174:349-55. [PMID: 16690977] CrossrefMedlineGoogle Scholar
    • 40. Pathan AA Wilkinson KA Klenerman P McShane H Davidson RN Pasvol G et alDirect ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol2001;167:5217-25. [PMID: 11673535] CrossrefMedlineGoogle Scholar
    • 41. Ewer K Deeks J Alvarez L Bryant G Waller S Andersen P et alComparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet2003;361:1168-73. [PMID: 12686038] CrossrefMedlineGoogle Scholar
    • 42. Nicol MP Pienaar D Wood K Eley B Wilkinson RJ Henderson H et alEnzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis2005;40:1301-8. [PMID: 15825033] CrossrefMedlineGoogle Scholar
    • 43. Pai M Joshi R Dogra S Mendiratta DK Narang P Dheda K et alPersistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol2006;1:7. [PMID: 16722616] CrossrefMedlineGoogle Scholar
    • 44. Ewer K Millington KA Deeks JJ Alvarez L Bryant G Lalvani A Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med2006;174:831-9. [PMID: 16799072] CrossrefMedlineGoogle Scholar
    • 45. Liebeschuetz S Bamber S Ewer K Deeks J Pathan AA Lalvani A Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet2004;364:2196-203. [PMID: 15610806] CrossrefMedlineGoogle Scholar
    • 46. Chapman AL Munkanta M Wilkinson KA Pathan AA Ewer K Ayles H et alRapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS2002;16:2285-93. [PMID: 12441800] CrossrefMedlineGoogle Scholar
    • 47. Piana F Codecasa LR Cavallerio P Ferrarese M Migliori GB Barbarano L et alUse of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients. Eur Respir J2006;28:31-4. [PMID: 16540502] CrossrefMedlineGoogle Scholar
    • 48. Passalent L Khan K Richardson R Wang J Deider H Gardam M Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and expert physician panel. Clin J Am Soc Nephrol2006;:1-6. MedlineGoogle Scholar
    • 49. Brock I Ruhwald M Lundgren B Westh H Mathiesen LR Ravn P Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res2006;7:56. [PMID: 16579856] CrossrefMedlineGoogle Scholar
    • 50. Connell TG Curtis N Ranganathan SC Buttery JP Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax2006;61:616-20. [PMID: 16601088] CrossrefMedlineGoogle Scholar
    • 51. Nakaoka H Lawson L Squire SB Coulter B Ravn P Brock I et alRisk for tuberculosis among children. Emerg Infect Dis2006;12:1383-8. [PMID: 17073087] CrossrefMedlineGoogle Scholar
    • 52. Tsiouris SJ Austin J Toro P Coetzee D Weyer K Stein Z et alResults of a tuberculosis-specific IFN-gamma assay in children at high risk for tuberculosis infection. Int J Tuberc Lung Dis2006;10:939-41. [PMID: 16898381] MedlineGoogle Scholar
    • 53. Soysal A Millington KA Bakir M Dosanjh D Aslan Y Deeks JJ et alEffect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet2005;366:1443-51. [PMID: 16243089] CrossrefMedlineGoogle Scholar
    • 54. Holden M Dubin MR Diamond PH Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N Engl J Med1971;285:1506-9. [PMID: 5127141] CrossrefMedlineGoogle Scholar
    • 55. Battershill JH Cutaneous testing in the elderly patient with tuberculosis. Chest1980;77:188-9. [PMID: 7353412] CrossrefMedlineGoogle Scholar
    • 56. Howard WL Klopfenstein MD Steininger WJ Woodruff CE The loss of tuberculin sensitivity in certain patients with active pulmonary tuberculosis. Chest1970;57:530-4. [PMID: 4994745] CrossrefMedlineGoogle Scholar
    • 57. Kardjito T Donosepoetro M Grange JM The Mantoux test in tuberculosis: correlations between the diameters of the dermal responses and the serum protein levels. Tubercle1981;62:31-5. [PMID: 7268918] CrossrefMedlineGoogle Scholar
    • 58. Stead WW To T The significance of the tuberculin skin test in elderly persons. Ann Intern Med1987;107:837-42. [PMID: 3688676] LinkGoogle Scholar
    • 59. Andersen P Munk ME Pollock JM Doherty TM Specific immune-based diagnosis of tuberculosis. Lancet2000;356:1099-104. [PMID: 11009160] CrossrefMedlineGoogle Scholar
    • 60. Farhat M Greenaway C Pai M Menzies D False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis2006;10:1192-204. [PMID: 17131776] MedlineGoogle Scholar
    • 61. World Health Organization. Global BCG vaccination coverage 2000-2005. Accessesed at www.who.int/immunization_monitoring/en/globalsummary/timeseries/tscoveragebcg.htm on 24 December 2005. Google Scholar
    • 62. Arend SM van Meijgaarden KE de Boer K de Palou EC van Soolingen D Ottenhoff TH et alTuberculin skin testing and in vitro T cell responses to ESAT-6 and culture filtrate protein 10 after infection with Mycobacterium marinum or M. kansasii. J Infect Dis2002;186:1797-807. [PMID: 12447766] CrossrefMedlineGoogle Scholar
    • 63. Palmer CE Edwards LB Identifying the tuberculous infected. The dual-test technique. JAMA1968;205:167-9. [PMID: 5694785] CrossrefMedlineGoogle Scholar
    • 64. Edwards LB Acquiviva FA Livesay VT Palmer CE An atlas of sensitivity to tuberculin and PPD-B in the United States. Am Rev Resp Dis1969;99:1-132. MedlineGoogle Scholar
    • 65. Pai M Riley LW Colford JM Jr Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis2004;4:761-76. [PMID: 15567126] CrossrefMedlineGoogle Scholar
    • 66. Richeldi L Ewer K Losi M Hansell DM Roversi P Fabbri LM et alEarly diagnosis of subclinical multidrug-resistant tuberculosis. Ann Intern Med2004;140:709-13. [PMID: 15126254] LinkGoogle Scholar
    • 67. Pai M Kalantri S Menzies D Discordance between tuberculin skin test and interferon-gamma assays [Letter]. Int J Tuberc Lung Dis2006;10:942-3. [PMID: 16898382] MedlineGoogle Scholar
    • 68. Brock I Munk ME Kok-Jensen A Andersen P Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis2001;5:462-7. [PMID: 11336278] MedlineGoogle Scholar
    • 69. Johnson PD Stuart RL Grayson ML Olden D Clancy A Ravn P et alTuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol1999;6:934-7. [PMID: 10548589] CrossrefMedlineGoogle Scholar
    • 70. Richeldi L Ewer K Losi M Bergamini BM Roversi P Deeks J et alT cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med2004;170:288-95. [PMID: 15130907] CrossrefMedlineGoogle Scholar
    • 71. Hill PC Brookes RH Fox A Fielding K Jeffries DJ Jackson-Sillah D et alLarge-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis2004;38:966-73. [PMID: 15034828] CrossrefMedlineGoogle Scholar
    • 72. Zellweger JP Zellweger A Ansermet S de Senarclens B Wrighton-Smith P Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis2005;9:1242-7. [PMID: 16333932] MedlineGoogle Scholar
    • 73. Shams H Weis SE Klucar P Lalvani A Moonan PK Pogoda JM et alEnzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med2005;172:1161-8. [PMID: 16081545] CrossrefMedlineGoogle Scholar
    • 74. TB. A global emergency, WHO, July 1994. Lepr Rev1995;66:270-1. [PMID: 7500828] MedlineGoogle Scholar
    • 75. Styblo K The relationship between the risk of tuberculosis infection and the risk of developing infectious tuberculosis. Bull Int Union Tuberc1985;60:117-19. Google Scholar
    • 76. Pai M Gokhale K Joshi R Dogra S Kalantri S Mendiratta DK et al Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA2005;293:2746-55. [PMID: 15941804] CrossrefMedlineGoogle Scholar
    • 77. Meier T Eulenbruch HP Wrighton-Smith P Enders G Regnath T Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis2005;24:529-36. [PMID: 16133410] CrossrefMedlineGoogle Scholar
    • 78. Carrara S Vincenti D Petrosillo N Amicosante M Girardi E Goletti D Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis2004;38:754-6. [PMID: 14986262] CrossrefMedlineGoogle Scholar
    • 79. Wilkinson KA Kon OM Newton SM Meintjes G Davidson RN Pasvol G et alEffect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis2006;193:354-9. [PMID: 16388482] CrossrefMedlineGoogle Scholar
    • 80. Mahomed H Hughes EJ Hawkridge T Minnies D Simon E Little F et alComparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis2006;10:310-6. [PMID: 16562712] MedlineGoogle Scholar
    • 81. Schölvinck E Wilkinson KA Whelan AO Martineau AR Levin M Wilkinson RJ Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods. J Clin Microbiol2004;42:829-31. [PMID: 14766863] CrossrefMedlineGoogle Scholar
    • 82. Dewan PK Grinsdale J Liska S Wong E Fallstad R Kawamura LM Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis2006;6:47. [PMID: 16539718] CrossrefMedlineGoogle Scholar
    • 83. Ravn P Munk ME Andersen AB Lundgren B Nielsen LN Lillebaek T et alReactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test. Scand J Infect Dis2004;36:499-501. [PMID: 15307581] CrossrefMedlineGoogle Scholar
    • 84. Ferrara G Losi M Meacci M Meccugni B Piro R Roversi P et alRoutine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med2005;172:631-5. [PMID: 15961696] CrossrefMedlineGoogle Scholar
    • 85. Mori T Sakatani M Yamagishi F Takashima T Kawabe Y Nagao K et alSpecific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med2004;170:59-64. [PMID: 15059788] CrossrefMedlineGoogle Scholar
    • 86. Taggart EW Hill HR Ruegner RG Litwin CM Evaluation of an in vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test. Am J Clin Pathol2006;125:467-73. [PMID: 16613353] CrossrefMedlineGoogle Scholar
    • 87. Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Kalantri S, et al. Preliminary results from an evaluation of a whole blood interferon-gamma assay in individuals with active tuberculosis in a rural Indian hospital. Infection. 2007; [In press]. Google Scholar
    • 88. Dewan PK Grinsdale J Kawamura LM Low sensitivity of a whole-blood interferon-gamma releaae assay for detection of active tuberculosis. Clin Infect Dis2007;44:69-73. [PMID: 17143818] CrossrefMedlineGoogle Scholar
    • A1. Dewan PK Grinsdale J Liska S Wong E Fallstad R Kawamura LM Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis2006;6:47. [PMID: 16539718] CrossrefMedlineGoogle Scholar
    • A2. Khan K Muennig P Behta M Zivin JG Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med2002;347:1850-9. [PMID: 12466510] CrossrefMedlineGoogle Scholar
    • A3. Oxlade O Schwartzman K Menzies D Interferon-gamma release assays and TB screening in high income countries: A cost effectiveness analysis. Int J Tuberc Lung Dis2007;11:16-26. [PMID: 17217125] MedlineGoogle Scholar
    • A4. Johnson PD Stuart RL Grayson ML Olden D Clancy A Ravn P et alTuberculin-purified protein derivative-, MPT-64-, and ESAT-6-stimulated gamma interferon responses in medical students before and after Mycobacterium bovis BCG vaccination and in patients with tuberculosis. Clin Diagn Lab Immunol1999;6:934-7. [PMID: 10548589] CrossrefMedlineGoogle Scholar
    • A5. Brock I Munk ME Kok-Jensen A Andersen P Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis2001;5:462-7. [PMID: 11336278] MedlineGoogle Scholar
    • A6. Mori T Sakatani M Yamagishi F Takashima T Kawabe Y Nagao K et alSpecific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med2004;170:59-64. [PMID: 15059788] CrossrefMedlineGoogle Scholar
    • A7. Kang YA Lee HW Yoon HI Cho B Han SK Shim YS et alDiscrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosisburden country. JAMA2005;293:2756-61. [PMID: 15941805] CrossrefMedlineGoogle Scholar
    • A8. Ravn P Munk ME Andersen AB Lundgren B Nielsen LN Lillebaek T et alReactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test. Scand J Infect Dis2004;36:499-501. [PMID: 15307581] CrossrefMedlineGoogle Scholar
    • A9. Ferrara G Losi M Meacci M Meccugni B Piro R Roversi P et alRoutine hospital use of a new commercial whole blood interferon-gamma assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med2005;172:631-5. [PMID: 15961696] CrossrefMedlineGoogle Scholar
    • A10. Connell TG Curtis N Ranganathan SC Buttery JP Performance of a whole blood interferon gamma assay for detecting latent infection with Mycobacterium tuberculosis in children. Thorax2006;61:616-20. [PMID: 16601088] CrossrefMedlineGoogle Scholar
    • A11. Ferrara G Losi M D’Amico R Roversi P Piro R Meacci M et alUse in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet2006;367:1328-34. [PMID: 16631911] CrossrefMedlineGoogle Scholar
    • A12. Lee JY Choi HJ Park IN Hong SB Oh YM Lim CM et alComparison of two commercial interferon-gamma assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J2006;28:24-30. [PMID: 16611658] CrossrefMedlineGoogle Scholar
    • A13. Goletti D Carrara S Vincenti D Saltini C Rizzi EB Schininà V et alAccuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study. Clin Microbiol Infect2006;12:544-50. [PMID: 16700703] CrossrefMedlineGoogle Scholar
    • A14. Dogra S, Narang P, Mendiratta DK, Chaturvedi P, Reingold AL, Colford JM Jr, et al. Comparison of a whole blood interferon-gamma assay with tuberculin skin testing for the detection of tuberculosis infection in hospitalized children in rural India. J Infect; 2006. DOI: 10.1016/J.Jinf.2006.04.007 (electronic access). [PMID: 16733068] Google Scholar
    • A15. Pai M Joshi R Dogra S Mendiratta DK Narang P Kalantri S et alPreliminary results from an evaluation of a whole blood interferon-gamma assay in individuals with active tuberculosis in a rural Indian hospital. Int J Tuber Lung Dis2005;:. Google Scholar
    • A16. Dewan PK Grinsdale J Kawamura LM Low sensitivity of a whole-blood interferon-gamma release assay for detection of active tuberculosis. Clin Infect Dis2007;44:69-73. [PMID: 17143818] CrossrefMedlineGoogle Scholar
    • A17. Lalvani A Pathan AA McShane H Wilkinson RJ Latif M Conlon CP et alRapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med2001;163:824-8. [PMID: 11282752] CrossrefMedlineGoogle Scholar
    • A18. Pathan AA Wilkinson KA Klenerman P McShane H Davidson RN Pasvol G et alDirect ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol2001;167:5217-25. [PMID: 11673535] CrossrefMedlineGoogle Scholar
    • A19. Lalvani A Nagvenkar P Udwadia Z Pathan AA Wilkinson KA Shastri JS et alEnumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis2001;183:469-77. [PMID: 11133379] CrossrefMedlineGoogle Scholar
    • A20. Chapman AL Munkanta M Wilkinson KA Pathan AA Ewer K Ayles H et alRapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS2002;16:2285-93. [PMID: 12441800] CrossrefMedlineGoogle Scholar
    • A21. Schölvinck E Wilkinson KA Whelan AO Martineau AR Levin M Wilkinson RJ Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods. J Clin Microbiol2004;42:829-31. [PMID: 14766863] CrossrefMedlineGoogle Scholar
    • A22. Liebeschuetz S Bamber S Ewer K Deeks J Pathan AA Lalvani A Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet2004;364:2196-203. [PMID: 15610806] CrossrefMedlineGoogle Scholar
    • A23. Nicol MP Pienaar D Wood K Eley B Wilkinson RJ Henderson H et alEnzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis2005;40:1301-8. [PMID: 15825033] CrossrefMedlineGoogle Scholar
    • A24. Aiken AM Hill PC Fox A McAdam KP Jackson-Sillah D Lugos MD et alReversion of the ELISPOT test after treatment in Gambian tuberculosis cases. BMC Infect Dis2006;6:66. [PMID: 16573826] CrossrefMedlineGoogle Scholar
    • A25. Meier T Eulenbruch HP Wrighton-Smith P Enders G Regnath T Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis2005;24:529-36. [PMID: 16133410] CrossrefMedlineGoogle Scholar
    • A26. Rolinck-Werninghaus C Magdorf K Stark K Lyashchenko K Gennaro ML Colangeli R et alThe potential of recombinant antigens ESAT-6, MPT63 and mig for specific discrimination of Mycobacterium tuberculosis and M. avium infection [Letter]. Eur J Pediatr2003;162:534-6. [PMID: 12715165] CrossrefMedlineGoogle Scholar
    • A27. Taggart EW Hill HR Ruegner RG Litwin CM Evaluation of an in vitro assay for interferon gamma production in response to the Mycobacterium tuberculosis-synthesized peptide antigens ESAT-6 and CFP-10 and the PPD skin test. Am J Clin Pathol2006;125:467-73. [PMID: 16613353] CrossrefMedlineGoogle Scholar
    • A28. Carrara S Vincenti D Petrosillo N Amicosante M Girardi E Goletti D Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis2004;38:754-6. [PMID: 14986262] CrossrefMedlineGoogle Scholar
    • A29. Wilkinson KA Kon OM Newton SM Meintjes G Davidson RN Pasvol G et alEffect of treatment of latent tuberculosis infection on the T cell response to Mycobacterium tuberculosis antigens. J Infect Dis2006;193:354-9. [PMID: 16388482] CrossrefMedlineGoogle Scholar
    • A30. Ewer K Millington KA Deeks JJ Alvarez L Bryant G Lalvani A Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med2006;174:831-9. [PMID: 16799072] CrossrefMedlineGoogle Scholar
    • A31. Pai M Joshi R Dogra S Mendiratta DK Narang P Dheda K et alPersistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol2006;1:7. [PMID: 16722616] CrossrefMedlineGoogle Scholar
    • A32. Lalvani A Pathan AA Durkan H Wilkinson KA Whelan A Deeks JJ et alEnhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet2001;357:2017-21. [PMID: 11438135] CrossrefMedlineGoogle Scholar
    • A33. Ewer K Deeks J Alvarez L Bryant G Waller S Andersen P et alComparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet2003;361:1168-73. [PMID: 12686038] CrossrefMedlineGoogle Scholar
    • A34. Richeldi L Ewer K Losi M Bergamini BM Roversi P Deeks J et alT cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med2004;170:288-95. [PMID: 15130907] CrossrefMedlineGoogle Scholar
    • A35. Hill PC Brookes RH Fox A Fielding K Jeffries DJ Jackson-Sillah D et alLarge-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis2004;38:966-73. [PMID: 15034828] CrossrefMedlineGoogle Scholar
    • A36. Zellweger JP Zellweger A Ansermet S de Senarclens B Wrighton-Smith P Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis2005;9:1242-7. [PMID: 16333932] MedlineGoogle Scholar
    • A37. Shams H Weis SE Klucar P Lalvani A Moonan PK Pogoda JM et alEnzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med2005;172:1161-8. [PMID: 16081545] CrossrefMedlineGoogle Scholar
    • A38. Hill PC Brookes RH Adetifa IM Fox A Jackson-Sillah D Lugos MD et alComparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics2006;117:1542-8. [PMID: 16651307] CrossrefMedlineGoogle Scholar
    • A39. Brock I Weldingh K Lillebaek T Follmann F Andersen P Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am J Respir Crit Care Med2004;170:65-9. [PMID: 15087297] CrossrefMedlineGoogle Scholar
    • A40. Nakaoka H Lawson L Squire SB Coulter B Ravn P Brock I et alRisk for tuberculosis among children. Emerg Infect Dis2006;12:1383-8. [PMID: 17073087] CrossrefMedlineGoogle Scholar
    • A41. Diel R Nienhaus A Lange C Meywald-Walter K Forssbohm M Schaberg T Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res2006;7:77. [PMID: 16707012] CrossrefMedlineGoogle Scholar
    • A42. Porsa E Cheng L Seale MM Delclos GL Ma X Reich R et alComparison of a new ESAT-6/CFP-10 peptide-based gamma interferon assay and a tuberculin skin test for tuberculosis screening in a moderate-risk population. Clin Vaccine Immunol2006;13:53-8. [PMID: 16426000] CrossrefMedlineGoogle Scholar
    • A43. Pai M Gokhale K Joshi R Dogra S Kalantri S Mendiratta DK et al Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA2005;293:2746-55. [PMID: 15941804] CrossrefMedlineGoogle Scholar
    • A44. Tsiouris SJ Austin J Toro P Coetzee D Weyer K Stein Z et alResults of a tuberculosis-specific IFN-gamma assay in children at high risk for tuberculosis infection. Int J Tuberc Lung Dis2006;10:939-41. [PMID: 16898381] MedlineGoogle Scholar
    • A45. Mahomed H Hughes EJ Hawkridge T Minnies D Simon E Little F et alComparison of mantoux skin test with three generations of a whole blood IFN-gamma assay for tuberculosis infection. Int J Tuberc Lung Dis2006;10:310-6. [PMID: 16562712] MedlineGoogle Scholar
    • A46. Harada N Nakajima Y Higuchi K Sekiya Y Rothel J Mori T Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect Control Hosp Epidemiol2006;27:442-8. [PMID: 16671023] CrossrefMedlineGoogle Scholar